Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer survivors may be at higher risk for cognitive dysfunction

01.06.2005


More research needed to clarify cause and extent of impairment, say USC psychologists



Cancer survivors are twice as likely to develop cognitive problems as individuals who have never been treated for cancer, according to an article in the June 1 Journal of the National Cancer Institute. Previous research has raised concerns about a possible link among cancer, cancer therapies and cognitive dysfunction. This study found that long-term cancer survivors were at increased risk of cognitive impairment. An accompanying editorial urged a cautious interpretation of the results pending further research.

In the study, USC psychologists studied 702 cancer survivors and their cancer-free twins in the Swedish Twin Registry. Studying twins removes statistical influences from genetic or early childhood causes of both cancer and cognitive deficits. Working with colleagues at the Karolinska Institute and Gothenberg University in Sweden, the researchers evaluated the survivors through a standardized mental status interview.


Participants were scored on a scale from zero to three. Anyone who scored a three, defined as having verbal, orientation or recall problems that interfere with daily life, was considered to have cognitive dysfunction. "The twin who had cancer was more likely to have some sort of cognitive dysfunction," said Beth Meyerowitz, professor of psychology in the USC College of Letters, Arts and Sciences. About 15 percent of the cancer survivors in the study showed cognitive dysfunction.

Previous studies have found cognitive problems in short-term cancer survivors, said coauthor Lara Heflin, a doctoral student in psychology at USC. This study is the first to find significant cognitive differences between long-term survivors and cancer-free individuals, she said, and to focus on older adult survivors. "This suggests that possibly the cognitive dysfunction gets worse over time with increased survival duration," Heflin said.

The comparison with cancer-free twins means that the increased dysfunction cannot be attributed to the normal aging process. The researchers also found a doubled risk of dementia in the survivor group. However, the result was not statistically significant.

Heflin plans to study patient data from Los Angeles County’s Cancer Surveillance Project and USC’s Alzheimer Disease Research Center to investigate the possible link between dementia and cancer.

The study does not suggest a cause for the cognitive problems in cancer survivors. The researchers excluded survivors of tumors that directly affect the central nervous system.

One possibility is that chemotherapy or other cancer treatments may cause long-term damage. The researchers plan a follow-up study comparing survivors who received different treatments. "If, five, eight, 10 years down the line, having had that treatment is going to increase a person’s risk of dementia, that’s something that should be considered by the physician and the patient," Meyerowitz said. "Maybe a lower dose might be useful for the cancer but would reduce risk of cognitive dysfunction."

"Those with cancer might also be advised to have their cognition monitored as part of long-term follow-up," added Margaret Gatz, professor of psychology at USC and foreign adjunct professor of medical epidemiology and biostatistics at the Karolinska Institute.

Carl Marziali | EurekAlert!
Further information:
http://www.usc.edu

More articles from Studies and Analyses:

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

European particle-accelerator community publishes the first industry compendium

26.04.2018 | Physics and Astronomy

Multifunctional bacterial microswimmer able to deliver cargo and destroy itself

26.04.2018 | Life Sciences

Why we need erasable MRI scans

26.04.2018 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>